These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9636695)
1. A structural switch in a mutant insulin exposes key residues for receptor binding. Ludvigsen S; Olsen HB; Kaarsholm NC J Mol Biol; 1998 May; 279(1):1-7. PubMed ID: 9636695 [TBL] [Abstract][Full Text] [Related]
2. Receptor binding redefined by a structural switch in a mutant human insulin. Hua QX; Shoelson SE; Kochoyan M; Weiss MA Nature; 1991 Nov; 354(6350):238-41. PubMed ID: 1961250 [TBL] [Abstract][Full Text] [Related]
3. Maintenance of the B-chain beta-turn in [GlyB24] insulin mutants: a steady-state fluorescence anisotropy study. Pittman I; Nakagawa SH; Tager HS; Steiner DF Biochemistry; 1997 Mar; 36(12):3430-7. PubMed ID: 9131992 [TBL] [Abstract][Full Text] [Related]
4. The relationship between insulin bioactivity and structure in the NH2-terminal A-chain helix. Olsen HB; Ludvigsen S; Kaarsholm NC J Mol Biol; 1998 Nov; 284(2):477-88. PubMed ID: 9813131 [TBL] [Abstract][Full Text] [Related]
5. Importance of the solvent-exposed residues of the insulin B chain alpha-helix for receptor binding. Glendorf T; Sørensen AR; Nishimura E; Pettersson I; Kjeldsen T Biochemistry; 2008 Apr; 47(16):4743-51. PubMed ID: 18376848 [TBL] [Abstract][Full Text] [Related]
6. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor. Xu B; Hu SQ; Chu YC; Huang K; Nakagawa SH; Whittaker J; Katsoyannis PG; Weiss MA Biochemistry; 2004 Jul; 43(26):8356-72. PubMed ID: 15222748 [TBL] [Abstract][Full Text] [Related]
7. How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor. Huang K; Xu B; Hu SQ; Chu YC; Hua QX; Qu Y; Li B; Wang S; Wang RY; Nakagawa SH; Theede AM; Whittaker J; De Meyts P; Katsoyannis PG; Weiss MA J Mol Biol; 2004 Aug; 341(2):529-50. PubMed ID: 15276842 [TBL] [Abstract][Full Text] [Related]
8. Nonlocal structural perturbations in a mutant human insulin: sequential resonance assignment and 13C-isotope-aided 2D-NMR studies of [PheB24-->Gly]insulin with implications for receptor recognition. Hua QX; Shoelson SE; Weiss MA Biochemistry; 1992 Dec; 31(47):11940-51. PubMed ID: 1445924 [TBL] [Abstract][Full Text] [Related]
9. Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain. Nakagawa SH; Zhao M; Hua QX; Hu SQ; Wan ZL; Jia W; Weiss MA Biochemistry; 2005 Apr; 44(13):4984-99. PubMed ID: 15794637 [TBL] [Abstract][Full Text] [Related]
10. The high resolution solution structure of the insulin monomer determined by NMR. Kaarsholm NC; Ludvigsen S Receptor; 1995; 5(1):1-8. PubMed ID: 7613479 [TBL] [Abstract][Full Text] [Related]
11. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama. Wan ZL; Huang K; Xu B; Hu SQ; Wang S; Chu YC; Katsoyannis PG; Weiss MA Biochemistry; 2005 Apr; 44(13):5000-16. PubMed ID: 15794638 [TBL] [Abstract][Full Text] [Related]
12. Chiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogue. Xu B; Hua QX; Nakagawa SH; Jia W; Chu YC; Katsoyannis PG; Weiss MA J Mol Biol; 2002 Feb; 316(3):435-41. PubMed ID: 11866509 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer. Zoete V; Meuwly M; Karplus M J Mol Biol; 2004 Sep; 342(3):913-29. PubMed ID: 15342246 [TBL] [Abstract][Full Text] [Related]
14. Structural interpretation of reduced insulin activity as seen in the crystal structure of human Arg-insulin. Sreekanth R; Pattabhi V; Rajan SS Biochimie; 2008 Mar; 90(3):467-73. PubMed ID: 18029081 [TBL] [Abstract][Full Text] [Related]
15. Crystal structure of allo-Ile(A2)-insulin, an inactive chiral analogue: implications for the mechanism of receptor binding. Wan ZL; Xu B; Chu YC; Katsoyannis PG; Weiss MA Biochemistry; 2003 Nov; 42(44):12770-83. PubMed ID: 14596591 [TBL] [Abstract][Full Text] [Related]
16. Non-standard insulin design: structure-activity relationships at the periphery of the insulin receptor. Weiss MA; Wan Z; Zhao M; Chu YC; Nakagawa SH; Burke GT; Jia W; Hellmich R; Katsoyannis PG J Mol Biol; 2002 Jan; 315(2):103-11. PubMed ID: 11779231 [TBL] [Abstract][Full Text] [Related]
17. Direct determination of the insulin-insulin receptor interface using transferred cross-saturation experiments. Nakamura T; Takahashi H; Takahashi M; Shimba N; Suzuki E; Shimada I J Med Chem; 2010 Mar; 53(5):1917-22. PubMed ID: 20158183 [TBL] [Abstract][Full Text] [Related]
18. Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus. Hua QX; Shoelson SE; Inouye K; Weiss MA Proc Natl Acad Sci U S A; 1993 Jan; 90(2):582-6. PubMed ID: 8421693 [TBL] [Abstract][Full Text] [Related]
19. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change. Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884 [TBL] [Abstract][Full Text] [Related]
20. Kinetic evidence for the sequential association of insulin binding sites 1 and 2 to the insulin receptor and the influence of receptor isoform. Thorsøe KS; Schlein M; Steensgaard DB; Brandt J; Schluckebier G; Naver H Biochemistry; 2010 Jul; 49(29):6234-46. PubMed ID: 20568733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]